New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.

Investors anticipate “bounce-back” in European private investment – Pharmaceutical Technology

Share this article At the Swiss Biotech Day conference, experts anticipated a recovery in the investment market. Credit: Scharvik via Getty Images The Swiss biotech

April 26, 2024

Opinion | Kim Kardashian’s Problematic Post Is About More Than MRIs

Brown is an emergency medicine physician and business expert. I have a confession to make. I’ve never watched an episode of “Keeping Up With the

August 31, 2023

23andMe’s independent board directors resign

Dive Brief: 23andMe’s independent board directors resigned on Tuesday amid uncertainty about the DNA testing company’s future. In a letter to CEO Anne Wojcicki, the

September 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.